HOTH THERAPEUTICS ($HOTH) posted quarterly earnings results on Monday, May 12th. The company reported earnings of -$0.27 per share, missing estimates of -$0.27 by $0.00. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $HOTH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
HOTH THERAPEUTICS Hedge Fund Activity
We have seen 5 institutional investors add shares of HOTH THERAPEUTICS stock to their portfolio, and 8 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HRT FINANCIAL LP removed 121,947 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $91,228
- UBS GROUP AG removed 25,471 shares (-45.1%) from their portfolio in Q4 2024, for an estimated $19,054
- VIRTU FINANCIAL LLC added 22,840 shares (+inf%) to their portfolio in Q1 2025, for an estimated $22,840
- TWO SIGMA SECURITIES, LLC added 13,576 shares (+72.9%) to their portfolio in Q4 2024, for an estimated $10,156
- GEODE CAPITAL MANAGEMENT, LLC added 13,038 shares (+15.7%) to their portfolio in Q4 2024, for an estimated $9,753
- TWO SIGMA INVESTMENTS, LP added 11,100 shares (+inf%) to their portfolio in Q4 2024, for an estimated $8,303
- CITIGROUP INC removed 4,553 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $4,553
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
HOTH THERAPEUTICS Analyst Ratings
Wall Street analysts have issued reports on $HOTH in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 01/07/2025
To track analyst ratings and price targets for HOTH THERAPEUTICS, check out Quiver Quantitative's $HOTH forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
